Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma.

MLA

Lozier, Ann M., et al. “Targeting Ornithine Decarboxylase Reverses the LIN28/Let-7 Axis and Inhibits Glycolytic Metabolism in Neuroblastoma.” Oncotarget, vol. 6, no. 1, Jan. 2015, pp. 196–206. EBSCOhost, https://doi.org/10.18632/oncotarget.2768.

APA

Lozier, A. M., Rich, M. E., Grawe, A. P., Peck, A. S., Zhao, P., Chang, A. T.-T., Bond, J. P., & Sholler, G. S. (2015). Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma. Oncotarget, 6(1), 196–206. https://doi.org/10.18632/oncotarget.2768

Chicago

Lozier, Ann M, Maria E Rich, Anissa Pedersen Grawe, Anderson S Peck, Ping Zhao, Anthony Ting-Tung Chang, Jeffrey P Bond, and Giselle Saulnier Sholler. 2015. “Targeting Ornithine Decarboxylase Reverses the LIN28/Let-7 Axis and Inhibits Glycolytic Metabolism in Neuroblastoma.” Oncotarget 6 (1): 196–206. doi:10.18632/oncotarget.2768.